Dr. Harish P – Medical Oncologist, Hemato-Oncologist & BMT Specialist in Bengaluru

Dr. Harish P is a Senior Consultant in Medical Oncology, Hemato-Oncology and Bone Marrow Transplantation (BMT) in Bengaluru. He has more than 18 years of overall clinical experience and specialises in the comprehensive management of solid tumours and haematological malignancies.

Dr. Harish P completed his MBBS from Bangalore Medical College and Research Institute, followed by MD in Internal Medicine from PGIMER, Chandigarh and DM in Medical Oncology from AIIMS, New Delhi. He has also completed MRCP (SCE) in Medical Oncology from the Federation of Royal Colleges of Physicians, United Kingdom.

His clinical expertise covers the diagnosis and treatment of a broad range of cancers, including breast, lung, gastrointestinal, gynaecological and genitourinary cancers, as well as haematological malignancies such as lymphoma, leukaemia and multiple myeloma.

Dr. Harish P has a special interest in precision oncology, molecular-guided treatment selection, targeted therapies, immunotherapy and systemic cancer treatment. He develops individualized treatment plans based on tumour biology, clinical findings and the patient's overall health.

His areas of expertise also include bone marrow transplant-related oncology, CAR-T cell therapy exposure, chemotherapy planning, toxicity management and supportive and palliative oncology. He has been involved in clinical research and oncology trials involving cancers such as lung cancer, breast cancer and multiple myeloma.

Dr. Harish P is associated with professional organisations including the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). His approach focuses on evidence-based, multidisciplinary and patient-centred cancer care.

Dr. Harish P's Medical Oncology Treatments

Medical Oncology

Comprehensive medical management of cancer using individualized treatment plans based on cancer type, stage, tumour biology and patient-specific factors.

Chemotherapy

Systemic anti-cancer treatment used to control or eliminate cancer cells and may be used alone or in combination with other treatments.

Immunotherapy

Cancer treatment that uses medicines designed to help the immune system recognize and respond to cancer cells in appropriately selected patients.

Targeted Therapy

Precision-based cancer treatment directed at specific molecular or biological features of a tumour when appropriate biomarkers are identified.

Precision Oncology

Individualized cancer treatment planning using tumour biology, molecular information and other clinical factors to guide therapy selection.

Breast Cancer Treatment

Multidisciplinary medical management of breast cancer, including systemic therapies selected according to tumour characteristics and disease stage.

Lung Cancer Treatment

Medical oncology care for lung cancer using chemotherapy, targeted therapy, immunotherapy and other appropriate systemic treatments.

Gastrointestinal Cancer Treatment

Medical management of selected gastrointestinal cancers with individualized systemic treatment based on diagnosis and tumour characteristics.

Gynaecological Cancer Treatment

Systemic cancer care for selected gynaecological malignancies as part of an individualized multidisciplinary treatment plan.

Haematological Cancer Treatment

Comprehensive medical management of cancers affecting blood, bone marrow and lymphatic tissues.

Lymphoma Treatment

Evaluation and systemic treatment of Hodgkin and non-Hodgkin lymphomas based on disease subtype, stage and individual factors.

Leukaemia Treatment

Specialist medical management of selected leukaemias using appropriate systemic therapies and supportive care.

Multiple Myeloma Treatment

Individualized treatment of multiple myeloma using appropriate systemic therapies and supportive management.

Bone Marrow Transplant

Specialist oncology care related to bone marrow transplantation, including assessment, treatment planning and transplant-related medical management.

CAR-T Cell Therapy

Advanced cellular cancer therapy involving genetically modified immune cells for selected eligible patients with certain malignancies.

Cancer Pain & Palliative Care

Supportive treatment focused on symptom control, pain management and quality of life for patients with advanced or complex cancers.